Nykode Therapeutics ASA (NYKD) — Free Cash Flow Generation Index

Latest as of March 2022: 0.85x

Nykode Therapeutics ASA (NYKD) has a Free Cash Flow Generation Index of 0.85x as of March 2022. Free cash flow of Nkr82.09 Million represents 1% of operating cash flow (Nkr96.14 Million). Explore NYKD capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.

FCF Generation Index

0.85x

Free Cash Flow / Operating CF

Free Cash Flow

Nkr82.09 Million

NOK

Operating Cash Flow

Nkr96.14 Million

NOK

Capital Expenditures

Nkr14.06 Million

NOK

Nykode Therapeutics ASA Free Cash Flow Generation Index (2020–2021)

Historical FCF Generation Index trend for Nykode Therapeutics ASA across 2 annual periods. For the full cash flow conversion analysis, see Nykode Therapeutics ASA (NYKD) cash conversion ratio.

Annual Free Cash Flow Generation for Nykode Therapeutics ASA (2020–2021)

Year-by-year Free Cash Flow Generation Index for Nykode Therapeutics ASA. Check NYKD total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.

Year	FCG Index	Free Cash Flow (NOK)	Operating CF	Capital Expenditures	YoY Change
2021	0.25x	Nkr284.00K	Nkr1.16 Million	Nkr871.00K	▼ -75.4%
2020	1.00x	Nkr180.17 Million	Nkr180.27 Million	Nkr99.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).